AARTIPHARM.NSAARTIPHARM.NSNSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+60.6%
5Y CAGR+699.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+60.6%/yr
Annual compound
5Y CAGR
+699.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
32649.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.10B | +444.9% |
| 2024 | $1.12B | -17.0% |
| 2023 | $1.35B | -8.4% |
| 2022 | $1.47B | +3202075.8% |
| 2021 | $45960.00 | -75.4% |
| 2020 | $186751.00 | - |